Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population

Journal of Virology

Volumn 80, Issue 21, 2006, Pages 10724-10733

  Arista, Serenella ^a,d   Giammanco, Giovanni M ^a   De Grazia, Simona ^a   Ramirez, Stefania ^a   Lo Biundo, Concetta ^a   Colomba, Claudia ^a   Cascio, Antonio ^b   Martella, Vito ^c  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d Dipartimento di Igiene e Microbiologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EVOLUTION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RECOMBINATION; HUMAN ROTAVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; VIRUS NEUTRALIZATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CAPSID PROTEINS; CHILD, PRESCHOOL; EVOLUTION, MOLECULAR; GENES, VIRAL; HUMANS; INFANT; ITALY; LONGITUDINAL STUDIES; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA-BINDING PROTEINS; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEQUENCE HOMOLOGY, AMINO ACID; SEROTYPING; VIRAL NONSTRUCTURAL PROTEINS;

HUMAN ROTAVIRUS A; ROTAVIRUS;

EID: 33750363837     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00340-06     Document Type: Article

References (64)

1. Arista, S., G. M. Giammanco, S. De Grazia, C. Colomba, and V. Martella. 2005. Genetic variability among serotype G4 Italian human rotaviruses. J. Clin. Microbiol. 43:1420-1425.
2. Arista, S., G. M. Giammanco, S. De Grazia, C. Colomba, V. Martella, A. Cascio, and M. Iturriza-Gomara. 2005. G2 rotavirus infections in an infantile population of the South of Italy: variability of viral strains over time. J. Med. Virol. 77:587-594.
3. Arista, S., G. M. Giammanco, S. De Grazia, M. C. Migliore, V. Martella, and A. Cascio. 2004. Molecular characterization of the genotype G9 human rotavirus strains recovered in Palermo, Italy, during the winter of 1999-2000. Epidemiol. Infect. 132:343-349.
4. Arista, S., L. Giovannelli, D. Pistoia, A. Cascio, M. Parea, and G. Gerna. 1990. Electropherotypes, subgroups and serotypes of human rotavirus strains causing gastroenteritis in infants and young children in Palermo, Italy, from 1985 to 1989. Res. Virol. 141:435-448.
5. Arista, S., E. Vizzi, D. Ferraro, A. Cascio, and R. Di Stefano. 1997. Distribution of VP7 serotypes and VP4 genotypes among rotavirus strains recovered from Italian children with diarrhea. Arch. Virol. 142:2065-2071.
6. Banyai, K., J. R. Gentsch, R. Schipp, F. Jakab, E. Meleg, I. Mihaly, and G. Szucs. 2005. Dominating prevalence of P[8],G1 and P[8],G9 rotavirus strains among children admitted to hospital between 2000 and 2003 in Budapest, Hungary. J. Med. Virol. 76:414-423.
7. Berois, M., S. Libersou, J. Russi, J. Arbiza, and J. Cohen. 2003. Genetic variation in the VP7 gene of human rotavirus isolated in Montevideo-Uruguay from 1996-1999. J. Med. Virol. 71:456-462.
8. Blackball, J., R. Bellinzoni, N. Mattion, M. K. Estes, J. L. La Torre, and G. Magnusson. 1992. A bovine rotavirus serotype 1: serologic characterization of the virus and nucleotide sequence determination of the structural glycoprotein VP7 gene. Virology 189:833-837.
9. Bon, F., C. Fromantin, S. Abo, P. Pothier, E. Kohli and the AZAY Group. 2000. G and P genotyping of rotavirus strains circulating in France over a three-year period: detection of G9 and P[6] strains at low frequencies. J. Clin. Microbiol. 38:1681-1683.
10. Boom, R., C. J. Sol, M. M. Salimans, C. L. Jansen, P. M. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
11. Buesa, J., C. O. de Souza, M. Asensi, C. Martinez, J. Prat, and M. T. Gil. 2000. VP7 and VP4 genotypes among rotavirus strains recovered from children with gastroenteritis over a 3-year period in Valencia, Spain. Eur. J. Epidemiol. 16:501-506.
12. Centers for Disease Control and Prevention. 1999. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 48:1-20.
13. Centers for Disease Control and Prevention. 1999. Withdrawal of rotavirus vaccine recommendation. Morb. Mortal. Wkly. Rep. 48:1007.
14. Ciarlet, M., Y. Hoshino, and F. Liprandi. 1997. Single point mutations may affect the serotype reactivity of serotype G11 porcine rotavirus strains: a widening spectrum? J. Virol. 71:8213-8220.
15. Ciarlet, M., and F. Liprandi. 1994. Serological and genomic characterization of two porcine rotaviruses with serotype G1 specificity. J. Clin. Microbiol. 32:269-272.
16. Clark, H. F., P. A. Offit, R. W. Ellis, J. J. Eiden, D. Krah, A. R. Shaw, M. Pichichero, J. J. Treanor, F. E. Borian, L. M. Bell, and S. A. Plotkin. 1996. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J. Infect. Dis. 174(Suppl. 1):S73-S80.
17. Coulson, B. S., K. J. Fowler, J. R. White, and R. G. Cotton. 1987. Non-neutralizing monoclonal antibodies to a trypsin-sensitive site on the major glycoprotein of rotavirus which discriminate between virus serotypes. Arch. Virol. 93:199-211.
18. Coulson, B. S., and C. Kirkwood. 1991. Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. J. Virol. 65:5968-5974.
19. Cunliffe, N. A., J. S. Gondwe, S. M. Graham, B. D. Thindwa, W. Dove, R. L. Broadhead, M. E. Molyneux, and C. A. Hart. 2001. Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J. Clin. Microbiol. 39:836-843.
20. De Vos, B., T. Vesikari, A. C. Linhares, B. Salinas, I. Perez-Schael, G. M. Ruiz-Palacios, L. Guerrero Mde, K. B. Phua, A. Delem, and K. Hardt. 2004. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 23:S179-S182.
21. Diwakarla, C. S., and E. A. Palombo. 1999. Genetic and antigenic variation of capsid protein VP7 of serotype G1 human rotavirus isolates. J. Gen. Virol. 80:341-344.
22. Dyall-Smith, M. L., I. Lazdins, G. W. Tregear, and I. H. Holmes. 1986. Location of the major antigenic sites involved in rotavirus serotype-specific neutralization. Proc. Natl. Acad. Sci. USA 83:3465-3468.
23. Estes, M. K. 2001. Rotaviruses and their replication, p. 1747-1785. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
24. Frenchick, P., M. I. Sabara, M. K. Ijak, and L. A. Babiuk. 1988. Immune responses to synthetic peptide vaccines of veterinary importance, p. 141-151. In B. Kurstak, R. G. Marusyk, F. A. Murphy, and M. H. V. Van Regenmortel (ed.), Applied virology research, vol. 1. Plenum Publishing Corp., New York, N.Y.
25. Gault, E., R. Chikhi-Brachet, S. Delon, N. Schnepf, L. Albiges, E. Grimprel, J. P. Girardet, P. Begue, and A. Garbarg-Chenon. 1999. Distribution of human rotavirus G types circulating in Paris, France, during the 1997-1998 epidemic: high prevalence of type G4. J. Clin. Microbiol. 37:2373-2375.
26. Gentsch, J. R., R. J. Glass, P. Woods, V. Gouvea, M. Gorziglia, J. Flores, B. K. Das, and M. K. Bhan. 1992. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 30:1365-1373.
27. Gentsch, J. R., P. A. Woods, M. Ramachandran, B. K. Das, J. P. Leite, A. Alfieri, R. Kumar, M. K. Bhan, and R. I. Glass. 1996. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J. Infect. Dis. 174(Suppl. 1):S30-S36.
28. Gouvea, V., R. I. Glass, P. Woods, K. Taniguchi, H. F. Clark, B. Forrester, and Z. Y. Fang. 1990. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J. Clin. Microbiol. 28:276-282.
29. Green, K. Y., and A. Z. Kapikian. 1992. Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. J. Virol. 66:548-553.
30. Hay, A. J., V. Gregory, A. R. Douglas, and Y. P. Lin. 2001. The evolution of human influenza viruses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:1861-1870.
31. Hoshino, Y., R. W. Jones, and A. Z. Kapikian. 2002. Characterization of neutralization specificities of outer capsid spike protein VP4 of selected murine, lapine, and human rotavirus strains. Virology 299:64-71.
32. Hoshino, Y., R. W. Jones, J. Ross, S. Honma, N. Santos, J. R. Gentsch, and A. Z. Kapikian. 2004. Rotavirus serotype G9 strains belonging to VF7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J. Virol. 78:7795-7802.
33. Hoshino, Y., L. J. Saif, M. M. Sereno, R. M. Chanock, and A. Z. Kapikian. 1988. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. J. Virol. 62:744-748.
34. Iturriza-Gomara, M., J. Green, D. W. Brown, U. Desselberger, and J. J. Gray. 1999. Comparison of specific and random priming in the reverse transcriptase polymerase chain reaction for genotyping group A rotaviruses. J. Virol. Methods 78:93-103.
35. Iturriza-Gomara, M., J. Green, D. W. Brown, M. Ramsay, U. Desselberger, and J. J. Gray. 2000. Molecular epidemiology of human group A rotavirus infections in the United Kingdom between 1995 and 1998. J. Clin. Microbiol. 38:4394-4401.
36. Iturriza-Gomara, M., G. Kang, and J. Gray. 2004. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J. Clin. Virol. 31:259-265.
37. Jin, Q., R. L. Ward, D. R. Knowlton, Y. B. Gabbay, A. C. Linhares, R. Rappaport, P. A. Woods, R. I. Glass, and J. R. Gentsch. 1996. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Arch. Virol. 141:2057-2076.
38. Kapikian, A. Z., Y. Hoshino, and R. M. Chanock. 2001. Rotaviruses, p. 1787-1833. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
39. Kobayashi, N., K. Taniguchi, T. Urasawa, and S. Urasawa. 1991. Analysis of the neutralization epitopes on human rotavirus VP7 recognized by monotype-specific monoclonal antibodies. J. Gen. Virol. 72:1855-1861.
40. Kumar, S., K. Tamura, and M. Nei. 2004. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5:150-163.
41. Laird, A. R., J. R. Gentsch, T. Nakagomi, O. Nakagomi, and R. I. Glass. 2003. Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001. J. Clin. Microbiol. 41:3100-3111.
42. Lee, C. N., C. C. Lin, C. L. Kao, C. L. Zao, M. C. Shih, and H. N. Chen. 2001. Genetic characterization of the rotaviruses associated with a nursery outbreak. J. Med. Virol. 63:311-320.
43. Li, B., and M. Gorziglia. 1993. VP4 serotype of the Gottfried strain of porcine rotavirus. J. Clin. Microbiol. 31:3075-3077.
44. Lindstrom, S. E., Y. Hiromoto, H. Nishimura, T. Saito, R. Nerome, and K. Nerome. 1999. Comparative analysis of evolutionary mechanisms of the hemagglutinin and three internal protein genes of influenza B virus: multiple cocirculating lineages and frequent reassortment of the NP, M, and NS genes. J. Virol. 73:4413-4426.
45. Lynch, M., B. Lee, P. Azimi, J. Gentsch, C. Glaser, S. Gilliam, H. G. Chang, R. Ward, and R. I. Glass. 2001. Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. Clin. Infect. Dis. 33:932-938.
46. Maunula, L., and C. H. van Bonsdorff. 1995. Rotavirus serotypes and electropherotypes in Finland from 1986 to 1990. Arch. Virol. 140:877-890.
47. Maunula, L., and C. H. von Bonsdorff. 1998. Short sequences define genetic lineages: phylogenetic analysis of group A rotaviruses based on partial sequences of genome segments 4 and 9. J. Gen. Virol. 79:321-332.
48. McCarthy, M. 2003. Project seeks to "fast track" rotavirus vaccine. Lancet 361:582.
49. Murphy, T. V., P. J. Smith, P. M. Gargiullo, and B. Schwartz. 2003. The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions. J. Infect. Dis. 187:1309-1313.
50. Nakagomi, T., Y. Horie, Y. Koshimura, H. B. Greenberg, and O. Nakagomi. 1999. Isolation of a human rotavirus strain with a super-short RNA pattern and a new P2 subtype. J. Clin. Microbiol. 37:1213-1216.
51. Nishikawa, K., Y. Hoshino, K. Taniguchi, K. Y. Green, H. B. Greenberg, A. Z. Kapikian, R. M. Chanock, and M. Gorziglia. 1989. Rotavirus VP7 neutralization epitopes of serotype 3 strains. Virology 171:503-515.
52. Offit, P. A. 1996. Host factors associated with protection against rotavirus disease: the skies are clearing. J. Infect. Dis. 174(Suppl. 1):S59-S64.
53. Offit, P. A., H. F. Clark, G. Blavat, and H. B. Greenberg. 1986. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J. Virol. 60:491-496.
54. O'Halloran, F., M. Lynch, B. Cryan, and S. Fanning. 2002. Application of restriction fragment length polymorphism analysis of VP7-encoding genes: fine comparison of Irish and global rotavirus isolates. J. Clin. Microbiol. 40:524-531.
55. Parashar, U. D., E. G. Hummelman, J. S. Bresee, M. A. Miller, and R. I. Glass. 2003. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9:565-572.
56. Rahman, M., J. Matthijnssens, S. Nahar, G. Podder, D. A. Sack, T. Azim, and M. Van Ranst. 2005. Characterization of a novel P[25],G11 human group a rotavirus. J. Clin. Microbiol. 43:3208-3212.
57. Salinas, B., J. Perez Schael, A. C. Linhares, G. M. Ruiz Palacios, M. L. Guerrero, J. P. Yarzabal, Y. Cervantes, S. Costa Clemens, S. Damaso, K. Hardt, and B. De Vos. 2005. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr. Infect. Dis. J. 24:807-816.
58. Sanchez-Fauquier, A., I. Wilhelmi, J. Colomina, E. Cubero, and E. Roman. 2004. Diversity of group A human rotavirus types circulating over a 4-year period in Madrid, Spain. J. Clin. Microbiol. 42:1609-1613.
59. Santos, N., and Y. Hoshino. 2005. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 15:29-56.
60. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
61. Velazquez, F. R., D. O. Matson, J. J. Calva, L. Guerrero, A. L. Morrow, S. Carter-Campbell, R. I. Glass, M. K. Estes, L. K. Pickering, and G. M. Ruiz-Palacios. 1996. Rotavirus infections in infants as protection against subsequent infections. N. Engl. J. Med. 335:1022-1028.
62. Ward, R. L., D. R. Knowlton, G. M. Schiff, Y. Hoshino, and H. B. Greenberg. 1988. Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J. Virol. 62:1543-1549.
63. Ward, R. L., M. M. McNeal, D. S. Sander, H. B. Greenberg, and D. I. Bernstein. 1993. Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children. J. Virol. 67:464-468.
64. Xin, K. Q., S. Morikawa, Z. Y. Fang, A. Mukoyama, K. Okuda, and H. Ushijima. 1993. Genetic variation in VP7 gene of human rotavirus serotype 1 (G1 type) isolated in Japan and China. Virology 197:813-816.